« Previous
Next »
European Journal of Internal Medicine
Volume 21, Issue 4
, Pages 289-292
, August 2010
Single nucleotide polymorphisms in inflammation-related genes are associated with venous thromboembolism
References
- Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med. 1994;179:1253–1259
- . Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study. J Thromb Haemost. 2004;2:619–622
- . Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis. Br J Haematol. 2002;116:173–177
- . Recurrent venous thrombosis and markers of inflammation. Thromb Haemost. 2000;83:536–539
- . Regulatory role in disseminated intravascular coagulation. Semin Thromb Hemost. 2001;27:639–651
- Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER study. Ann N Y Acad Sci. 2007;1100:189–198
- Prevalence of OPG and IL-1 gene polymorphisms in chronic periodontitis. J Clin Periodontol. 2007;34:823–827
- Association of IL10 promoter polymorphism in Italian Alzheimer's disease. Neurosci Lett. 2007;418:262–265
- Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis. Ann Neurol. 2004;55:793–800
- . The risk of recurrent venous thromboembolism in men and women. N Engl J Med. 2004;350:2558–2563
- . Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis. Lancet. 2006;368:371–378
- . Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med. 2002;162:1182–1189
- Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg. 2007;45:335–342
- . The effects of race/ethnicity and sex on the risk of venous thromboembolism. Curr Opin Pulm Med. 2007;13:377–383
- . Gender differences in the innate immune response and vascular reactivity following the administration of endotoxin to human volunteers. Crit Care Med. 2007;35:1464–1469
- . Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med. 2000;26:167–172
- The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998;102:1369–1376
- Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases?. Clin Chem. 2004;50:2136–2140
- Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha. Immunogenetics. 2002;54:82–86
- . Can the interleukin-6 response to endotoxin be predicted? Studies of the influence of a promoter polymorphism of the interleukin-6 gene, gender, the density of the endotoxin receptor CD14, and inflammatory cytokines. Crit Care Med. 2002;30:664–669
- . Gender differences in IL-1α, IL1-β and IL-1 receptor antagonist secretion from mononuclear cells and urinary secretion. J Immunol. 1994;153:300–306
- . Link between arterial and venous disease. J Internal Medicine. 2007;262:341–350
- Gene expression profile related to inflammation in rat model of traumatic deep vein thrombosis. Chin J Traumatol. 2007;10:206–212
- . Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha. Haematologica. 1999;84:306–311
- . Cytokines: triggers of clinical thrombotic disease. Thromb Haemost. 1997;78:415–419
- . Inhibition of IL-1 induced tissue factor (TF) synthesis and procoagulant activity (PCA) in purified human monocytes by IL-4, IL-10 and IL-13. Cytokine. 1996;8:822–827
- . Protein S is inducible by interleukin 4 in T cells and inhibits lymphoid cell procoagulant activity. Proc Natl Acad Sci U S A. 1997;94:11484–11489
- . Gender differences in genetic risk profiles for cardiovascular disease. PLoS ONE. 2008;3(10):e3615
- Interleukin-6 gene −
174
g
>
c and −
572
g
>
c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol. 2001;21:1458–1463 - Interleukin-6 and interleukin-6 promoter polymorphism (−
174) G
>
C in patients with spontaneous venous thromboembolism. Thromb Haemost. 2006;95:802–806 - . The blood coagulation mechanism in multiple myeloma. Semin Thromb Hemost. 2003;29:275–282
- . Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study. J Thromb Haemost. 2004;2:619–622
- . Inflammatory cytokines as risk factors for a first venous thrombosis: a prospective population-based study. PLoS Med. 2006;3:e334
PII: S0953-6205(10)00062-2
doi: 10.1016/j.ejim.2010.04.001
© 2010 European Federation of Internal Medicine. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
European Journal of Internal Medicine
Volume 21, Issue 4
, Pages 289-292
, August 2010
